Where does Lieber Institute, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Lieber Institute, Inc. ranks #32,342 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Lieber Institute, Inc. hold?

Lieber Institute, Inc. holds 8 US utility patents granted between 2019 and 2025, spanning 5 technology areas.

What is Lieber Institute, Inc.'s Innovation Score?

Lieber Institute, Inc. has an Innovation Score of 35.5 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Lieber Institute, Inc.'s patent grant rate increasing or decreasing?

Lieber Institute, Inc.'s recent grant velocity is +500% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Lieber Institute, Inc.'s patents?

Lieber Institute, Inc.'s patents average 25.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Lieber Institute, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Lieber Institute, Inc.

Q: What technology areas does Lieber Institute, Inc. focus on?

Lieber Institute, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 8 patents. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 5 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Lieber ranks #32,342 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 5 technology areas.

#32,342
of 49,997 US assignees by volume: Top 49%
by Innovation Score (35.5/100): 25.5
avg claims per patent: +500%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R32342 · US Corporation #32,342 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #32,342/49,997
PHOTO-FINISH Li &
CPC-NARROW A61P · 5 areas
INNOV-THIN 35.5/100
CLAIMS-DENSE 25.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +500% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Li & Co AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Diam UK · near

36
Focaltech · near

36
Fujian Xihe… · near

36
Innogy Innovation · near

36
Lieber Institute · this assignee

36
3D Lighting… · lowest

7

What this shows Lieber's Innovation Score is 35.5/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Lieber's grants concentrate

Lieber Institute, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2019. By volume, Lieber sits between Li & Co AG and Lilt, Inc..

Lieber's three-year grant acceleration

Lieber Institute, Inc. shows 3 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Li &

8
Li Industries

8
Libertine FPE

8
Liberty Reach

8
Lifefactory

8
Lightfleet

8
Lightship Medical

8
Lilt

8
Lieber Institute ◀

8

What this shows Lieber holds 8 patents at rank #32,358, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Lieber

By rank, the assignees closest to #32,358 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Lieber's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Lieber, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Innogy Innovation GmbH 36 Focaltech Electronics, Ltd. 36 Fujian Xihe Sanitary Ware Technology Co., Ltd. 36 Diam UK Ltd 36

Lieber's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Lieber Institute, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	12.5%
2020	1	12.5%
2021	2	25.0%
2022	1	12.5%
2024	2	25.0%
2025partial year	1	12.5%

Which technologies does Lieber Institute, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

C07D - Heterocyclic Compounds 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#32,342

of 49,997 tracked assignees

Innovation Score

35.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Lieber Institute, Inc.'s patent record in context - here's where to go next.

Lieber Institute, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #32,342 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Lieber Institute, Inc. against Li & Co AG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.